686 results on '"EGAN, BRENT M."'
Search Results
2. General Principles, Etiologies, Evaluation, and Management in Older Adults
3. Abstract 17562: Real-World Evidence for Comparative Effectiveness of Antihypertensive Therapeutic Intensification Strategies: Increasing Dose versus Adding a New Medication
4. Abstract 17555: Are Intermittent BP Control and Patient Complexity Barriers to Antihypertensive Treatment Intensification for Uncontrolled BP?
5. Sociodemographic Determinants of Life’s Simple 7 : Implications for Achieving Cardiovascular Health and Health Equity Goals
6. Visceral adiposity syndrome and cardiometabolism
7. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
8. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines
9. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
10. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association
11. Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults.
12. Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database
13. Implementation of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline: Opportunity for a Public Health and Population Healthcare Collaborative
14. Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol: Results at 6 and 12 Months
15. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment
16. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
17. The prevalence of concurrently raised blood glucose and blood pressure in India
18. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard?
19. Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
20. Prognostic value of blood pressure control delay in newly diagnosed hypertensive patients
21. Implementation Strategies to Improve Blood Pressure Control in the United States: A Scientific Statement From the American Heart Association and American Medical Association.
22. Characteristics of Adults With Apparent Treatment Resistant Hypertension: Six Factors Impacting Prevalence--Editorial Commentary.
23. Social and Medical Determinants of Cardiometabolic Health : The Big Picture
24. Weight Loss Pharmacotherapy : Brief Summary of the Clinical Literature and Comments on Racial Differences
25. Treatment Resistant Hypertension
26. Diabetes and age-related demographic differences in risk factor control
27. Role of Aldosterone Blockade in Resistant Hypertension
28. Decreased Heart Rate Variability is Associated with Increased Transcranial doppler Velocities in Children with Sickle Cell Disease
29. TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.
30. Trends in Hypertension Control Among United States Adults: Is NHANES the Outlier?
31. Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial
32. Comparative effectiveness research in the “real” world: lessons learned in a study of treatment-resistant hypertension
33. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion
34. Physical Activity and Hypertension: Knowing Is Not Enough; We Must Apply. Willing Is Not Enough; We Must Do—von Goethe
35. Relationship between risk factor control and vascular events in the SAMMPRIS trial
36. Demographic Differences in the Treatment and Control of Glucose in Type 2 Diabetic Patients : Implications for Health Care Practice
37. Cardiovascular Disease Risk Factor Clustering among African American Adults
38. REPLY: The importance of masked hypertension in adults with prehypertension
39. Evidence Linking Fatty Fat Acids, the Risk Factor Cluster, and Vascular Pathophysiology : Implications for the Diabetic Hypertensive Patient
40. Concordance Between Self-Reported Heights and Weights and Current and Ideal Body Images in Young Adult African American Men and Women
41. Age and Race Impact the Association between BMI and CVD Mortality in Women
42. Ethnic, Gender, and Age-Related Differences in Treatment and Control of Dyslipidemia in Hypertensive Patients
43. Prevalence, Treatment, and Control of Hypertension Among African Americans and Caucasians at Primary Care Sites for Medically Under-served Patients
44. Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy.
45. Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.
46. Pre-Hypertension: Rationale for Pharmacotherapy
47. Prevalence of hypertension by duration and age at exposure to the stroke belt
48. Prehypertension: An Opportunity for a New Public Health Paradigm
49. Efficacy of a Church-Based Intervention on Cardiovascular Risk Reduction
50. Short-Term Impact of a Church-Based Approach to Lifestyle Change on Cardiovascular Risk in African Americans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.